$LFT
Lument Finance Trust, Inc. Stock $lft

$lft Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000162828024011505 Filed on March 15, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$35.44M	$32.48M	$109.2M
YoY Change	59.6%	68.46%	92.63%
Cost Of Revenue	$22.45M	$23.39M	$74.80M
YoY Change	60.81%	88.71%	127.98%
Gross Profit	$12.99M	$9.093M	$34.39M
YoY Change	57.55%	32.02%	44.06%
Gross Profit Margin	36.66%	27.99%	31.5%
Selling, General & Admin	$4.231M	$2.595M	$10.10M
YoY Change	62.28%	4.91%	0.72%
% of Gross Profit	32.57%	28.54%	29.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$6.045M	$4.068M	$14.78M
YoY Change	142.53%	-17.5%	1.28%
Operating Profit	$6.948M	$5.025M	$19.61M
YoY Change	20.75%	156.82%	111.29%
Interest Expense	$4.630K	-$56.33K	-$103.7K
YoY Change	-109.42%	153.17%	-142.55%
% of Operating Profit	0.07%	-1.12%	-0.53%
Other Income/Expense, Net
YoY Change
Pretax Income	$6.991M	$5.010M	$19.72M
YoY Change	21.45%	138.96%	99.7%
Income Tax	$10.89K	-$4.060K	$5.720K
% Of Pretax Income	0.16%	-0.08%	0.03%
Net Earnings	$6.980M	$3.829M	$14.97M
YoY Change	21.04%	335.21%	51.81%
Net Earnings / Revenue	19.69%	11.79%	13.71%
Basic Earnings Per Share	$0.11		$0.29
Diluted Earnings Per Share	$0.11	$0.07	$0.29
COMMON SHARES
Basic Shares Outstanding	52.25M shares	52.23M shares	52.23M shares
Diluted Shares Outstanding	52.25M shares		52.23M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$64.57M	$51.25M	$51.25M
YoY Change	-34.49%	16.85%	16.85%
Cash & Equivalents	$64.57M	$51.25M	$51.25M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$90.36M	$59.84M	$59.84M
YoY Change	-13.95%	20.5%	20.5%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$72.18K	$270.1K	$270.1K
YoY Change	-96.29%	-92.3%	-92.3%
Total Long-Term Assets	$1.288B	$1.387B	$1.387B
YoY Change	26.08%	28.64%	28.64%
TOTAL ASSETS
Total Short-Term Assets	$90.36M	$59.84M	$59.84M
Total Long-Term Assets	$1.288B	$1.387B	$1.387B
Total Assets	$1.378B	$1.447B	$1.447B
YoY Change	22.35%	28.28%	28.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$3.851M	$4.093M	$4.093M
YoY Change	53.72%	73.36%	73.36%
Deferred Revenue
YoY Change
Short-Term Debt	$1.076B	$1.146B	$1.146B
YoY Change	29.64%	38.21%	38.21%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.087B	$1.157B	$1.157B
YoY Change	29.69%	38.01%	38.01%
LONG-TERM LIABILITIES
Long-Term Debt	$47.28M	$47.22M	$47.22M
YoY Change	0.53%	0.53%	0.53%
Other Long-Term Liabilities	$501.7K	$2.374M	$2.374M
YoY Change	37.1%	306.45%	306.45%
Total Long-Term Liabilities	$47.78M	$49.59M	$49.59M
YoY Change	1.6%	5.58%	5.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.087B	$1.157B	$1.157B
Total Long-Term Liabilities	$47.78M	$49.59M	$49.59M
Total Liabilities	$1.135B	$1.206B	$1.206B
YoY Change	28.19%	36.3%	36.29%
SHAREHOLDERS EQUITY
Retained Earnings	$54.35M	$47.37M
YoY Change	62.61%	51.59%
Common Stock	$522.6K	$522.5K
YoY Change	0.06%	0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$242.8M	$240.7M	$240.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.378B	$1.447B	$1.447B
YoY Change	22.35%	28.28%	28.28%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$6.980M	$3.829M	$14.97M
YoY Change	21.04%	335.21%	51.81%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$9.058M	$9.225M	$24.74M
YoY Change	55.05%	102.64%	51.87%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$80.09M	-$2.537M	-$316.7M
YoY Change	55.14%	-91.42%	511.05%
Cash From Investing Activities	$80.09M	-$2.537M	-$316.7M
YoY Change	55.14%	-91.42%	511.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$39.90K
YoY Change			-99.95%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$76.02M	-4.805M	296.1M
YoY Change	1661.78%	11.16%	358.2%
NET CHANGE
Cash From Operating Activities	$9.058M	9.225M	24.74M
Cash From Investing Activities	$80.09M	-2.537M	-316.7M
Cash From Financing Activities	-$76.02M	-4.805M	296.1M
Net Change In Cash	$13.13M	1.883M	4.151M
YoY Change	-75.3%	-106.42%	-85.73%
FREE CASH FLOW
Cash From Operating Activities	$9.058M	$9.225M	$24.74M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Registrant Name EntityRegistrantName	LUMENT FINANCE TRUST, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-4966519
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	230 Park Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	20th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10169
CY2023	dei	City Area Code CityAreaCode	212
CY2023	dei	Local Phone Number LocalPhoneNumber	317-5700
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51247063	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	270129	usd
CY2023Q4	hcft	Mortgage Service Rights At Fair Value MortgageServiceRightsAtFairValue	691973	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	8588805	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	2116007	usd
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	46971042	usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2400000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52231152	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52231152	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	243001497	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001547546
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-35845
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	52300000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	52248631	shares
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43858515	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3507850	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1389940203	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1076148186	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	6059006	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	4258668	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1383881197	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1071889518	usd
CY2022Q4	hcft	Mortgage Service Rights At Fair Value MortgageServiceRightsAtFairValue	795656	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	5797991	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	2253280	usd
CY2023Q4	us-gaap	Assets Assets	1446932447	usd
CY2022Q4	us-gaap	Assets Assets	1127965537	usd
CY2023Q4	hcft	Collateralized Loan Obligations And Secured Financing Net CollateralizedLoanObligationsAndSecuredFinancingNet	1146210752	usd
CY2022Q4	hcft	Collateralized Loan Obligations And Secured Financing Net CollateralizedLoanObligationsAndSecuredFinancingNet	829310498	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	47220226	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	4092701	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2360809	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	4654904	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	4131369	usd
CY2023Q4	hcft	Management Fees And Expenses Payable ManagementFeesAndExpensesPayable	1587875	usd
CY2022Q4	hcft	Management Fees And Expenses Payable ManagementFeesAndExpensesPayable	1606333	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	2373609	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	583989	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1206140067	usd
CY2022Q4	us-gaap	Liabilities Liabilities	884964040	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.07875
CY2023	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.07875
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	60000000	usd
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	60000000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2400000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2400000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2400000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	57254935	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	57254935	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52248631	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52248631	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	522487	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	522252	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	314587299	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	314598384	usd
CY2023Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	179045749	usd
CY2022Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	160724426	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	47373908	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	31250852	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	240692880	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	242901997	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	99500	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	99500	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240792380	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	243001497	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1446932447	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1127965537	usd
CY2023	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	106821510	usd
CY2022	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	56610324	usd
CY2023	hcft	Interest Expense Collateralized Loan Obligations And Secured Financings InterestExpenseCollateralizedLoanObligationsAndSecuredFinancings	71041861	usd
CY2022	hcft	Interest Expense Collateralized Loan Obligations And Secured Financings InterestExpenseCollateralizedLoanObligationsAndSecuredFinancings	29055324	usd
CY2023	hcft	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	3759141	usd
CY2022	hcft	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	3754872	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	34392996	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	23874804	usd
CY2023	hcft	Management And Incentive Fees ManagementAndIncentiveFees	4335904	usd
CY2022	hcft	Management And Incentive Fees ManagementAndIncentiveFees	4197819	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3620589	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3467653	usd
CY2023	hcft	Reimbursable Operating Expense ReimbursableOperatingExpense	1897699	usd
CY2022	hcft	Reimbursable Operating Expense ReimbursableOperatingExpense	2116636	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2158488	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-309797	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	241194	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	240980	usd
CY2023	us-gaap	Noninterest Expense NoninterestExpense	12253874	usd
CY2022	us-gaap	Noninterest Expense NoninterestExpense	10332885	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	2524216	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	4258668	usd
CY2023	hcft	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-103684	usd
CY2022	hcft	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	243659	usd
CY2023	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	208997	usd
CY2022	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	347838	usd
CY2023	hcft	Other Noninterest Income Loss OtherNoninterestIncomeLoss	-2418903	usd
CY2022	hcft	Other Noninterest Income Loss OtherNoninterestIncomeLoss	-3667171	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	19720219	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	9874748	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5723	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11088	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	19714496	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9863660	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4740000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4740000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5123660	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14974496	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	14974496	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5123660	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5123660	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52231296	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48342347	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.26
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.24
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	169375500	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	83487253	usd
CY2022	hcft	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	2446970	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-2830	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9863660	usd
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	12535116	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	4740000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	243001497	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	53516	usd
CY2023	hcft	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	56940	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-7426	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	19714496	usd
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	13581323	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	4740000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240792380	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	19714496	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9863660	usd
CY2023	hcft	Accretion Of Discounts On Held For Investment Loans AccretionOfDiscountsOnHeldForInvestmentLoans	1070701	usd
CY2022	hcft	Accretion Of Discounts On Held For Investment Loans AccretionOfDiscountsOnHeldForInvestmentLoans	125098	usd
CY2023	hcft	Amortization Of Premiums On Held For Investment Loans AmortizationOfPremiumsOnHeldForInvestmentLoans	19253	usd
CY2022	hcft	Amortization Of Premiums On Held For Investment Loans AmortizationOfPremiumsOnHeldForInvestmentLoans	61144	usd
CY2023	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	292073	usd
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	27084	usd
CY2023	hcft	Amortization Of Offering Costs AmortizationOfOfferingCosts	-56940	usd
CY2022	hcft	Amortization Of Offering Costs AmortizationOfOfferingCosts	-114571	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3258892	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2772870	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	2524216	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	4258668	usd
CY2023	hcft	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-103684	usd
CY2022	hcft	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	243659	usd
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	6194	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	15980	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2790814	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1820239	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	137272	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	226749	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1731892	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1656754	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-18458	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-218809	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1745972	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	436187	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24738341	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16289054	usd
CY2023	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	594201680	usd
CY2022	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	345921827	usd
CY2023	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	277481511	usd
CY2022	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	293326723	usd
CY2023	us-gaap	Increase Decrease In Deferred Charges Investing IncreaseDecreaseInDeferredChargesInvesting	0	usd
CY2022	us-gaap	Increase Decrease In Deferred Charges Investing IncreaseDecreaseInDeferredChargesInvesting	-763250	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-316720169	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-51831854	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	39896	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	81136045	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13057788	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	11646557	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	4740000	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	4740000	usd
CY2023	hcft	Proceeds From Collateralized Loan Obligations ProceedsFromCollateralizedLoanObligations	317700000	usd
CY2022	hcft	Proceeds From Collateralized Loan Obligations ProceedsFromCollateralizedLoanObligations	0	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3809453	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	119375	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	296132655	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	64630113	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4150827	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	29087313	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47366365	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18279052	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51517192	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47366365	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	69810218	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	28380571	usd
CY2023	hcft	Dividends Declared Not Yet Paid DividendsDeclaredNotYetPaid	4654904	usd
CY2022	hcft	Dividends Declared Not Yet Paid DividendsDeclaredNotYetPaid	4315119	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The financial statements have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires the Company to make a number of significant estimates. These include estimates of fair value of certain assets and liabilities, amount and timing of credit losses, prepayment rates, and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the financial statements and the reported amounts of certain revenues and expenses during the reported period. It is likely that changes in these estimates (e.g. valuation changes due to supply and demand, credit performance, prepayments, interest rates, or other reasons) will occur in the near term. The Company's estimates are inherently subjective in nature and actual results could differ from its estimates and the differences may be material.</span></div>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51247063	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43858515	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51517192	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47366365	usd
CY2023Q4	hcft	Number Of Commercial Real Estate Loans Included In Loan Performance Analytical Model NumberOfCommercialRealEstateLoansIncludedInLoanPerformanceAnalyticalModel	100000	loan
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1076148186	usd
CY2022Q4	us-gaap	Allowance For Loan And Lease Losses Real Estate AllowanceForLoanAndLeaseLossesRealEstate	4258668	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1071889518	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	583989	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	31250852	usd
CY2023Q4	hcft	Number Of Sub Servers NumberOfSubServers	2	sub-servicer
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52248631	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52248631	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	6059006	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	4258668	usd
CY2022Q4	hcft	One Month Libor Rate OneMonthLIBORRate	0.0418
CY2023Q4	hcft	One Month Sofr Rate OneMonthSOFRRate	0.0533
CY2022Q4	hcft	One Month Sofr Rate OneMonthSOFRRate	0.0419
CY2023Q4	hcft	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0038	usd
CY2022Q4	hcft	Weighted Average Sofr Floor Rate WeightedAverageSOFRFloorRate	0.0027
CY2023Q4	hcft	Weighted Average Floating Rate WeightedAverageFloatingRate	1.000
CY2022	hcft	Financing Receivable Floating Rate Percentage FinancingReceivableFloatingRatePercentage	0.774
CY2022Q4	hcft	Weighted Average Sofr Rate WeightedAverageSOFRRate	0.226
CY2023Q4	hcft	Average Risk Rate AverageRiskRate	3.5
CY2022Q4	hcft	Average Risk Rate AverageRiskRate	3.0
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	4258668	usd
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	2522510	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	4258668	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	6059006	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	4258668	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	6059006	usd
CY2023Q4	hcft	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments	43647	usd
CY2023Q4	hcft	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Including Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestIncludingUnfundedLoanCommitments	6102653	usd
CY2023Q4	hcft	Financing Receivable Excluding Accrued Interest Net Of Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestNetOfAllowanceForCreditLoss	1397385160	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	4258668	usd
CY2022Q4	hcft	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments	0	usd
CY2022Q4	hcft	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Including Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestIncludingUnfundedLoanCommitments	4258668	usd
CY2022Q4	hcft	Financing Receivable Excluding Accrued Interest Net Of Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestNetOfAllowanceForCreditLoss	10258668	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	2500000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	6100000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	6000000	usd
CY2022	hcft	Reserve For Impaired Loan ReserveForImpairedLoan	4300000	usd
CY2023	hcft	Reserve For Impaired Loan ReserveForImpairedLoan	4300000	usd
CY2023Q4	hcft	Impaired Financing Receivable Unpaid Principal Balance Interest Accrual Status ImpairedFinancingReceivableUnpaidPrincipalBalanceInterestAccrualStatus	19600000	usd
CY2021Q2	hcft	Number Of Newly Formed Subsidiaries NumberOfNewlyFormedSubsidiaries	2	subsidiary
CY2021Q2	hcft	Variable Interest Entity Qualitative And Quantitative Information Equity Interest VariableInterestEntityQualitativeAndQuantitativeInformationEquityInterest	96250000	usd
CY2021Q2	hcft	Proceeds From Issuance Of Debt Securities Allocated To Acquire Additional Loan Obligations ProceedsFromIssuanceOfDebtSecuritiesAllocatedToAcquireAdditionalLoanObligations	330300000	usd
CY2021Q2	hcft	Period To Acquire Additional Loan Obligations From Closing Date PeriodToAcquireAdditionalLoanObligationsFromClosingDate	P180D
CY2021Q2	hcft	Collateralized Loan Obligation Leverage Ratio CollateralizedLoanObligationLeverageRatio	0.83
CY2022Q4	hcft	One Month Libor Rate OneMonthLIBORRate	0.0418
CY2023Q4	hcft	One Month Sofr Rate OneMonthSOFRRate	0.0533
CY2022Q4	hcft	One Month Sofr Rate OneMonthSOFRRate	0.0419
CY2023Q4	hcft	Weighted Average Libor Floor Rate Collateralized Loan Obligations WeightedAverageLIBORFloorRateCollateralizedLoanObligations	0.0038
CY2022Q4	hcft	Weighted Average Libor Floor Rate Collateralized Loan Obligations WeightedAverageLIBORFloorRateCollateralizedLoanObligations	0.0025
CY2023	us-gaap	Loans Receivable Basis Spread On Variable Rate During Period LoansReceivableBasisSpreadOnVariableRateDuringPeriod	0.0199
CY2022	us-gaap	Loans Receivable Basis Spread On Variable Rate During Period LoansReceivableBasisSpreadOnVariableRateDuringPeriod	0.0143
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	hcft	Collateralized Loan Obligation Unamortized Discount CollateralizedLoanObligationUnamortizedDiscount	39200000	usd
CY2023Q4	hcft	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	529774	usd
CY2022Q4	hcft	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	778958	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2023Q4	hcft	Number Of Sub Servers NumberOfSubServers	2	sub-servicer
CY2023	hcft	Servicing Liability At Fair Value Change In Fair Value Valuation Input Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag ServicingLiabilityAtFairValueChangeInFairValueValuationInputStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag	consolidated statements of operations
CY2022	hcft	Servicing Liability At Fair Value Other Change In Fair Value Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag ServicingLiabilityAtFairValueOtherChangeInFairValueStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag	consolidated statements of operations
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	691973	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	795656	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51247063	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1383881197	usd
CY2023Q4	hcft	Collateralized Loan Obligations And Secured Financing Net CollateralizedLoanObligationsAndSecuredFinancingNet	1146210752	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	47220226	usd
CY2023	hcft	Annual Management Fee Percentage AnnualManagementFeePercentage	0.015
CY2023	hcft	Quarterly Management Fee Percentage QuarterlyManagementFeePercentage	0.00375
CY2023	hcft	Reduction To Reimbursable Expenses As Percentage Of Waived Exit Fees Percent ReductionToReimbursableExpensesAsPercentageOfWaivedExitFeesPercent	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52248631	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52248631	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52231152	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52231152	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2400000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2400000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2400000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2400000	shares
CY2023Q2	hcft	Fair Market Value Average Closing Prices Share Of Common Stock Reported Nyse Period FairMarketValueAverageClosingPricesShareOfCommonStockReportedNYSEPeriod	10	tradingday
CY2023	us-gaap	Net Income Loss NetIncomeLoss	19714496	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9863660	usd
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	13581323	usd
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	12535116	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	4740000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	4740000	usd
CY2023	us-gaap	Dividends Dividends	18321323	usd
CY2022	us-gaap	Dividends Dividends	17275116	usd
CY2023	us-gaap	Undistributed Earnings UndistributedEarnings	1393173	usd
CY2022	us-gaap	Undistributed Earnings UndistributedEarnings	-7411456	usd
CY2022Q4	hcft	Deferred Tax Assets Mortgage Servicing Rights DeferredTaxAssetsMortgageServicingRights	19456	usd
CY2023Q4	hcft	Deferred Tax Assets Capitalized Transaction Costs DeferredTaxAssetsCapitalizedTransactionCosts	68862	usd
CY2022Q4	hcft	Deferred Tax Assets Capitalized Transaction Costs DeferredTaxAssetsCapitalizedTransactionCosts	81382	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52228567	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48337029	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2729	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5318	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52231296	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48342347	shares
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5723	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	11088	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5723	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11088	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.201
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.004
CY2023	hcft	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	0.000
CY2022	hcft	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	-0.006
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2023Q4	hcft	Deferred Tax Liabilities Accumulated Net Operating Losses DeferredTaxLiabilitiesAccumulatedNetOperatingLosses	1372235	usd
CY2022Q4	hcft	Deferred Tax Liabilities Accumulated Net Operating Losses DeferredTaxLiabilitiesAccumulatedNetOperatingLosses	1229334	usd
CY2023Q4	hcft	Deferred Tax Assets Mortgage Servicing Rights DeferredTaxAssetsMortgageServicingRights	-116648	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1324449	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1330172	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4500000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4000000	usd
CY2023Q4	srt	Mortgage Loans On Real Estate Prior Liens1 MortgageLoansOnRealEstatePriorLiens1	0	usd
CY2023Q4	hcft	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Unpaid Principal Balance SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateUnpaidPrincipalBalance	1397385160	usd
CY2023Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1383881197	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1071889518	usd
CY2021Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1001825294	usd
CY2023	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	594201680	usd
CY2022	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	345158577	usd
CY2023	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	277481511	usd
CY2022	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	270926723	usd
CY2023	hcft	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Accretion Of Purchase Discount SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAccretionOfPurchaseDiscount	1070701	usd
CY2022	hcft	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Accretion Of Purchase Discount SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAccretionOfPurchaseDiscount	125098	usd
CY2023	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	19253	usd
CY2022	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	61144	usd
CY2023	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	292073	usd
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	27084	usd
CY2023	hcft	Provision For Mortgage Loans ProvisionForMortgageLoans	2522510	usd
CY2022	hcft	Provision For Mortgage Loans ProvisionForMortgageLoans	4258668	usd
CY2023Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1383881197	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1071889518	usd

Files In Submission

Name	View Source	Status
0001628280-24-011505-index-headers.html	Edgar Link	pending
0001628280-24-011505-index.html	Edgar Link	pending
0001628280-24-011505.txt	Edgar Link	pending
0001628280-24-011505-xbrl.zip	Edgar Link	pending
exhibit971.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hcft-20231231.htm	Edgar Link	pending
hcft-20231231.xsd	Edgar Link	pending
hcft-20231231_g1.jpg	Edgar Link	pending
hcft-20231231_g2.jpg	Edgar Link	pending
hcft-20231231_g3.jpg	Edgar Link	pending
lft10-k20231231_ex21x1.htm	Edgar Link	pending
lft10-k20231231_ex23x1.htm	Edgar Link	pending
lft10-k20231231_ex31x1.htm	Edgar Link	pending
lft10-k20231231_ex31x2.htm	Edgar Link	pending
lft10-k20231231_ex32x1.htm	Edgar Link	pending
lft10-k20231231_ex32x2.htm	Edgar Link	pending
lft10-k20231231_ex4x3.htm	Edgar Link	pending
lft10-k20231231_ex99x1.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hcft-20231231_cal.xml	Edgar Link	unprocessable
hcft-20231231_def.xml	Edgar Link	unprocessable
hcft-20231231_lab.xml	Edgar Link	unprocessable
hcft-20231231_pre.xml	Edgar Link	unprocessable
hcft-20231231_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFT
Lument Finance Trust, Inc. Stock $lft

2024 Q1 Form 10-K Financial Statement

#000162828024011505 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT Lument Finance Trust, Inc. Stock $lft

2024 Q1 Form 10-K Financial Statement

#000162828024011505 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT
Lument Finance Trust, Inc. Stock $lft